Help us reach our goal of $150,000 to fight for psychedelic freedom in Ontario's Court of Appeal. Donate now.

About Us

Our Story Our Story Our Values Our Sacred Values Our Team Our Team Community Guidelines Code of Ethics FAQ PAC Business Alliance Inclusion, Diversity and Social Justice

Get Involved

Become a Member Become a PAC Business Alliance Member Make a Donation Sponsorship Volunteer

Events Our Impact

Drug Information

drugscience.org.uk Alcohol Adderall
Alkyl Nitrites (Poppers)Amphetamine Ayahuasca Benzodiazepines Buprenorphine Caffeine Cannabis Cocaine DMT (N,N-Dimethyltryptamine)Fentanyl Flunitrazepam (Rohypnol)GHB/GBL Heroin Ibogaine Kava Ketamine Khat Kratom LSD (Lysergic Acid Diethylamide)MDMA (Ecstasy)Mephedrone (Meow Meow)Methadone Methamphetamine Methaqualone (Quaaludes)Methoxetamine Modafinil Nicotine (Tobacco)Nitrous Oxide (Laughing Gas)Phencyclidine (PCP)Psilocybin (Magic Mushrooms)Salvia Synthetic cannabinoids (Spice)Testosterone 2C-B 5-MeO-DMT (Bufo)Films Podcasts Talks

Clinical Trials

Ethics

Code of Ethics Harm Reduction How to Find a Therapist How to Work Through “Cancel Requests”Best Practices for Psychedelic Practitioners How To Navigate Touch in Therapy How To Respond To Ethical Breaches How to be Part of a Ethical Therapist Accountability Group Ethical Considerations for Journalism and Media in the Psychedelic Ecosystem 5 -MeO-DMT Code of Ethics Suggested Practice Standards - Ketamine Clinics in Canada Professional Practice Guidelines for Psychedelic Assisted Therapy Inclusion, Diversity and Social Justice Please do not call yourself a Healer

Resources

Our Blog Our Youtube Channel Harm Reduction How to Find a Therapist

Campaign Resources

Decriminalization Parliament Petition Reading Media Organizations Memorandum of Regulatory Analysis Documentaries 2021 Nanos Poll for Psilocybin at End of Life patients Films Podcasts Talks

Marketplace Training Programs Reading List Events & Conferences Press Releases

Media

Media Organizations Documentaries Films Podcasts Talks

Global Psychedelic Organizations Clinical Trials Research Findings Research Search Tool MAPS Canada SAP Tips

Allies

Psychedelic Non Profits - Friends and Allies Global Psychedelic Organizations Media Organizations Worldwide Psychedelic Legal Status

Decriminalization

Decriminalize Canada

Decriminalize Kingston

Decriminalize Nature USA

Decriminalize Toronto

Decriminalize Vancouver

United States

US - Port Townsend, WA

US - Washington State

Contact

Join

Join the PAC Join the Business Alliance

Donate

Donate to the PAC Sponsor the PAC

Training

Resources:

Contribute to research Help fund research How to join a trial

Levels of Psychedelic-Assisted Therapy Training

University-Level Graduate or Post-Graduate Programs with Supervised Practicum

This training is for:
Licensed or graduate-level clinicians, researchers, and healthcare professionals seeking advanced certification or specialization in psychedelic-assisted therapy.

This allows you to:
Integrate psychedelic-assisted therapy into clinical practice under a regulated framework, contribute to research, and meet competency standards for ethical and safe delivery of psychedelic therapies. Graduates typically complete both academic courses and supervised practicums.

The level of oversight is:
High. Direct supervision is provided by faculty and licensed clinical supervisors, and projects or practicum placements are governed by academic and ethical review boards.